Lista de obras - Kelly-Anne Phillips - Dominio Público Uruguay

10-year performance of four models of breast cancer risk: a validation study

artículo científico publicado en 2019

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

artículo científico publicado en 2014

A case of early-stage epithelial ovarian cancer in pregnancy

artículo científico publicado en 2001

A decision aid for women at increased risk for ovarian cancer

artículo científico publicado en 2003

A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer

artículo científico publicado en 2004

A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer

artículo científico publicado en 2006

Abortion and breast cancer risk for Australian women

artículo científico publicado en 2014

Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool

artículo científico publicado en 2019

Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions

artículo científico publicado en 2003

Adjuvant ovarian function suppression and cognitive function in women with breast cancer.

artículo científico publicado en 2016

Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)

Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry

artículo científico publicado en 2005

Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

scientific article published on 02 December 2019

Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)

scientific article published on 28 November 2019

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource

artículo científico publicado en 2006

Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors

artículo científico publicado en 2008

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

artículo científico publicado en 2015

Anti-Müllerian Hormone Serum Concentrations of Women With Germline BRCA1 or BRCA2 Mutations

Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations

artículo científico publicado en 2016

Assessing and managing breast cancer risk: clinicians' current practice and future needs

artículo científico publicado en 2014

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

artículo científico publicado en 2015

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

artículo científico publicado en 2015

Association analysis identifies 65 new breast cancer risk loci.

artículo científico publicado en 2017

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

artículo científico publicado en 2016

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Australian clinicians and chemoprevention for women at high familial risk for breast cancer

artículo científico publicado en 2009

Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics

artículo científico publicado en 2003

Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort

scientific article published on 20 February 2019

Body mass index and breast cancer survival: a Mendelian randomization analysis

artículo científico publicado en 2017

Breast Cancer Chemoprevention: Use and Views of Australian Women and their Clinicians

artículo científico publicado en 2020

Breast Cancer Prognosis inBRCA1andBRCA2Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study

article

Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry

artículo científico publicado en 2015

Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?

artículo científico publicado en 2014

Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab

artículo científico publicado en 2016

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

artículo científico publicado en 2016

Breast carcinoma in carriers of BRCA1 or BRCA2 mutations: implications of proposed distinct histologic phenotypes

artículo científico publicado en 1998

Breast conservation in BRCA1 or BRCA2 mutation carriers with early stage breast cancer.

artículo científico publicado en 2001

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer

artículo científico publicado en 2012

Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer

artículo científico publicado en 2007

Clinical management of women at high risk of breast cancer

artículo científico publicado en 2015

Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy

artículo científico publicado en 2003

Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC)

artículo científico publicado en 2015

Common germline polymorphisms associated with breast cancer-specific survival

artículo científico publicado en 2015

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort

artículo científico publicado en 2020

Conservative management of reproductive cancers. Ovarian protection during treatment

scientific article published on 28 June 2018

Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results

artículo científico publicado en 2019

Contralateral prophylactic mastectomy (CPM): A systematic review of patient reported factors and psychological predictors influencing choice and satisfaction

artículo científico publicado en 2016

Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).

scientific article published on 11 August 2009

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2020

Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment

artículo científico publicado en 2023

Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer

artículo científico publicado en 2013

Do aromatase inhibitors have adverse effects on cognitive function?

artículo científico publicado en 2011

Does stress increase risk of breast cancer? A 15-year prospective study

scientific article published on 04 May 2018

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials

artículo científico publicado en 2017

Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry

artículo científico publicado en 2008

Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer

artículo científico publicado en 2005

Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriers.

artículo científico publicado en 2010

Genetic testing in women with breast cancer: implications for treatment

artículo científico publicado en 2017

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

artículo científico publicado en 2016

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

scientific article published on 18 May 2020

Genome-wide linkage screen for testicular germ cell tumour susceptibility loci

artículo científico publicado en 2006

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

artículo científico publicado en 2015

HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

artículo científico publicado en 2002

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

artículo científico publicado en 2017

Identification of novel genetic markers of breast cancer survival

artículo científico publicado en 2015

Key steps for effective breast cancer prevention

artículo científico publicado en 2020

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

artículo científico publicado en 2010

Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary tale

artículo científico publicado en 2006

Massive oxidative haemolysis and renal failure caused by high dose vitamin C

artículo científico publicado en 2018

Medication to prevent breast cancer--too much to swallow?

scientific article published on 01 December 2011

Medication to reduce breast cancer risk: why is uptake low?

artículo científico publicado en 2016

Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer

artículo científico publicado en 2014

Morphological predictors of BRCA1 germline mutations in young women with breast cancer.

artículo científico publicado en 2011

Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation

artículo científico publicado en 2005

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

artículo científico publicado en 2015

Obesity and outcomes in premenopausal and postmenopausal breast cancer

artículo científico publicado en 2005

Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study

artículo científico publicado en 2018

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry

artículo científico publicado en 2010

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

artículo científico publicado en 2020

Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry

artículo científico publicado en 2009

Predicting women's intentions for contralateral prophylactic mastectomy: An application of an extended theory of planned behaviour.

artículo científico publicado en 2016

Predictors of breast cancer screening behavior in women with a strong family history of the disease

artículo científico publicado en 2010

Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort

artículo científico publicado en 2005

Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer

artículo científico publicado en 2008

Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2013

Preventing ovarian failure associated with chemotherapy

article

Prognosis of Premenopausal Breast Cancer and Childbirth Prior to Diagnosis

article

Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study

scientific article published on 21 November 2019

Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families

artículo científico publicado en 2011

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers

artículo científico publicado en 2007

Psychosocial factors and survival of young women with breast cancer: a population-based prospective cohort study

artículo científico publicado en 2008

Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer

artículo científico publicado en 2013

Putting the risk of breast cancer in perspective

scientific article published on 01 January 1999

Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic Risk

scientific article published on 02 October 2019

Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study

Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy

artículo científico publicado en 2009

Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk

scientific article published on 01 March 2019

Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199)

artículo científico publicado en 2019

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

scientific article published on 16 January 2020

Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer

artículo científico publicado en 2006

Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study

artículo científico publicado en 2006

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2017

Screening behavior in women at increased familial risk for breast cancer

artículo científico publicado en 2006

Socio-economic status and survival from breast cancer for young, Australian, urban women

artículo científico publicado en 2010

Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2013

Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer.

artículo científico publicado en 2017

The International Testicular Cancer Linkage Consortium: a clinicopathologic descriptive analysis of 461 familial malignant testicular germ cell tumor kindred

artículo científico publicado en 2009

The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation

artículo científico publicado en 2020

The Y deletion gr/gr and susceptibility to testicular germ cell tumor

artículo científico publicado en 2005

The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing

scientific article published on 07 November 2018

The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing. (Preprint)

preprint

The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

artículo científico publicado en 2005

The role of genetic breast cancer susceptibility variants as prognostic factors

artículo científico publicado en 2012

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

artículo científico publicado en 2020

Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?

artículo científico publicado en 2015

Unexpected diagnosis of spinal leptomeningeal metastatic disease on MRI myelography

artículo científico publicado en 2019

Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model

artículo científico publicado en 2013

Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers.

artículo científico publicado en 2012

Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situ

artículo científico publicado en 2018

What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?

artículo científico publicado en 2005

Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?

artículo científico publicado en 2016

Women's preferences for contralateral prophylactic mastectomy: An investigation using protection motivation theory

artículo científico publicado en 2016

Women's preferences for selective estrogen reuptake modulators: an investigation using protection motivation theory

artículo científico publicado en 2014

Women's preferences for selective estrogen reuptake modulators: an investigation using the time trade-off technique

artículo científico publicado en 2014

Younger age-at-diagnosis for familial malignant testicular germ cell tumor

artículo científico publicado en 2009

iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management

artículo científico publicado en 2016

Lista de obras de Kelly-Anne Phillips

10-year performance of four models of breast cancer risk: a validation study

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

A case of early-stage epithelial ovarian cancer in pregnancy

A decision aid for women at increased risk for ovarian cancer

A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer

A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer

Abortion and breast cancer risk for Australian women

Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool

Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions

Adjuvant ovarian function suppression and cognitive function in women with breast cancer.

Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)

Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry

Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort Consortium

Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource

Analysis of the DND1 gene in men with sporadic and familial testicular germ cell tumors

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

Anti-Müllerian Hormone Serum Concentrations of Women With Germline BRCA1 or BRCA2 Mutations

Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations

Assessing and managing breast cancer risk: clinicians' current practice and future needs

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

Association analysis identifies 65 new breast cancer risk loci.

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

Australian clinicians and chemoprevention for women at high familial risk for breast cancer

Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics

Benign breast disease increases breast cancer risk independent of underlying familial risk profile: Findings from a Prospective Family Study Cohort

Body mass index and breast cancer survival: a Mendelian randomization analysis

Breast Cancer Chemoprevention: Use and Views of Australian Women and their Clinicians

Breast Cancer Prognosis inBRCA1andBRCA2Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study

Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry

Breast cancer prevention for BRCA1 and BRCA2 mutation carriers: is there a role for tamoxifen?

Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.

Breast carcinoma in carriers of BRCA1 or BRCA2 mutations: implications of proposed distinct histologic phenotypes

Breast conservation in BRCA1 or BRCA2 mutation carriers with early stage breast cancer.

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer

Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer

Clinical management of women at high risk of breast cancer

Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy

Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC)

Common germline polymorphisms associated with breast cancer-specific survival

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort

Conservative management of reproductive cancers. Ovarian protection during treatment

Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results

Contralateral prophylactic mastectomy (CPM): A systematic review of patient reported factors and psychological predictors influencing choice and satisfaction

Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).

Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment

Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer

Do aromatase inhibitors have adverse effects on cognitive function?

Does stress increase risk of breast cancer? A 15-year prospective study

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials

Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry

Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer

Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriers.

Genetic testing in women with breast cancer: implications for treatment

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

Genome-wide linkage screen for testicular germ cell tumour susceptibility loci

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Identification of novel genetic markers of breast cancer survival

Key steps for effective breast cancer prevention

Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy

Loss of heterozygosity analysis in ductal lavage samples from BRCA1 and BRCA2 carriers: a cautionary tale

Massive oxidative haemolysis and renal failure caused by high dose vitamin C

Medication to prevent breast cancer--too much to swallow?

Medication to reduce breast cancer risk: why is uptake low?

Misperceptions of ovarian cancer risk in women at increased risk for hereditary ovarian cancer

Morphological predictors of BRCA1 germline mutations in young women with breast cancer.

Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Obesity and outcomes in premenopausal and postmenopausal breast cancer

Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers